1
/
of
0
FDA Drug Approval, N018304, SENSORCAINE
FDA Drug Approval, N018304, SENSORCAINE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018304
Company: FRESENIUS KABI USA
Drug Name: SENSORCAINE
Active Ingredients: BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Strength: 0.75%;0.0091MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/30/1981
Marketing Status: Prescription
Submission Classification:
Company: FRESENIUS KABI USA
Drug Name: SENSORCAINE
Active Ingredients: BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Strength: 0.75%;0.0091MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/30/1981
Marketing Status: Prescription
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details